![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Watch CNBC's full interview with Sarepta CEO Doug Ingram (CNBC Television) View |
![]() |
Sarepta CEO on what's next after expanded muscular dystrophy drug approval (CNBC Television) View |
![]() |
Watch CNBC's full interview with Regeneron CEO Len Schleifer (CNBC Television) View |
![]() |
Biotech analyst discusses her top stock picks: Biogen u0026 Sarepta Therapeutics (CNBC Television) View |
![]() |
In the Pipeline: Gene Therapy - Sarepta Therapeutics (Parent Project Muscular Dystrophy) View |
![]() |
Watch CNBC's full interview with Cigna CEO David Cordani (CNBC Television) View |
![]() |
Sarepta Therapeutics Chart Analysis – Explosive Options (Explosive Options) View |
![]() |
ImClone Systems founder Sam Waksal on drug pricing (CNBC Television) View |
![]() |
We're expecting to get at least six drug approvals from the FDA in 2020: GlaxoSmithKline CEO (CNBC Television) View |
![]() |
U.S. Can't Afford Medicare for All, Centene CEO Says (Bloomberg Television) View |